←
Tim Yu426 posts
Tim Yu avatar

Tim Yu

@timyu

Neuroscience, Genetics, Genomic Medicine. Tweets my own unless one of our girls has broken into my account again in which case sorry for all the Pokémon pics

◷ Joined July 2007▧ 17 Photos and videos
Tim Yu avatar
Tim Yu@timyu·10 Oct 2019

1/3 Wonderful to finally be able to share our paper on the development and deployment of milasen, now online at nejm.org/doi/full/10.1056/NE…. It’s accompanied by thoughtful commentary from Janet Woodcock and Peter Marks of the FDA (nejm.org/doi/full/10.1056/NE…).

Broad Institute avatar
⟳ Tim Yu retweeted
Broad Institute@broadinstitute·24 Jun 2025

Gene editing pioneer @davidrliu discusses baby K.J. Muldoon, the first person treated with a customized gene editing therapy, what made K.J.'s treatment possible, and how on-demand treatments for rare genetic diseases could one day become routine. broad.io/DLQA

Post attachment
Tim Yu avatar
Tim Yu@timyu·15 May 2025

Privileged to be a physician-scientist in a time when efforts like these spanning genetics, engineering, & medicine come to fruition. Hats off to @kiranmusunuru, Rebecca Ahrens-Niklas ,@UrnovFyodor & more for this milestone in interventional genetics. nejm.org/doi/full/10.1056/NE…

Marlen Lauffer avatar
⟳ Tim Yu retweeted
Marlen Lauffer@LaufferMarlen·4 Oct 2024

David Cheerie and I will present at the first @N1Collaborative annual meeting tomorrow! We will discuss the newly established N1C VARIANT (Variant Assessments towards Eligibility for Antisense Oligonucleotide Treatment) Guidelines. medrxiv.org/content/10.1101/…

ForeBatten Foundation avatar
⟳ Tim Yu retweeted
ForeBatten Foundation@forebatten·25 Sep 2024

Announcing Zebronkysen: Amelia & Makenzie receive personalized ASO drug. This milestone would not be possible without the incredible support of the ForeBatten community and the passionate development team. More information on this exciting news is on forebatten.org/

Post attachment
AnnemiekeAartsma-Rus avatar
⟳ Tim Yu retweeted
AnnemiekeAartsma-Rus@oligogirl·24 Sep 2024

Thanks to co-authors @roon_mom @LaufferMarlen @collinrwj @ypeelgersma The paper describes how @timyu & @stopbatten inspired us to start DCRT and lessons we have learned in our first 4 years (spoiler: most important lesson: it is important to collaborate & share @N1Collaborative)

Our paper on the DCRT is out now in @TARareDisease Joining forces to develop individualized antisense oligonucleotides for patients with brain or eye diseases: the example of the Dutch Center for RNA Therapeutics - (sagepub.com)

David R. Liu avatar
⟳ Tim Yu retweeted
David R. Liu@davidrliu·23 Apr 2024

This Thursday April 25 from 4:00-6:30 pm at the Broad Institute Julia Vitarello (Mila's mom @stopbatten), Casey McPherson (Rose's dad @ToCureARose), @The_Termeer_Fdn, @Cookies4Cures, @broadinstitute, and others will host "Rock n' Rare", a special event of inspirational stories and music celebrating family and friends of rare disease patients, scientists, doctors, and the interested public. Stories and appearances by Julia, Casey, @timyu, @SammyBasso, Dana Perella, Cole Quinn, Weston McPherson, and myself. Music by Casey McPherson and AlphaRev. Registration: betterunite.com/rocknrare

Post attachment
Marlen Lauffer avatar
⟳ Tim Yu retweeted
Marlen Lauffer@LaufferMarlen·19 Apr 2024

Very happy that our recommendations for the identification of suitable variants for individualized ASO treatments are now published! Big thanks go to our PhD candidate Bianca Zardetto, @oligogirl, @roon_mom, and our colleagues from the @N1Collaborative hindawi.com/journals/humu/20…

Eric Vallabh Minikel avatar
⟳ Tim Yu retweeted
Eric Vallabh Minikel@cureffi·17 Apr 2024

Published today, our reasons for optimism that success rates in drug discovery can be improved by picking the right targets using human genetics: nature.com/articles/s41586-0… I break the key findings down panel by panel in this thread:

Post attachment

Is having even more gene-disease associations still useful for picking drug targets? For which types of programs does it matter? Has pharma shifted focus towards genetically validated targets? New paper by me, @mnelsonxy, @DongCoco90417, & @jivecast doi.org/10.1101/2023.06.23.2…👇

Post attachment
Tim Yu avatar
Tim Yu@timyu·9 Apr 2024

Montage: Totality -4 min, Totality -10 sec, Totality -5 sec, 1st min of totality, 2nd min of totality, 3rd min of totality, Totality +3 sec, Totality +5 sec, Totality +2 min

Mila's Miracle avatar
⟳ Tim Yu retweeted
Mila's Miracle@stopbatten·3 Apr 2024

Thank you @natashaloder and The @Telegraph for sharing Mila's story and the critical role the UK is playing in proving a model for individualized medicines at scale. telegraph.co.uk/global-healt…